10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
9.16
-0.25 (-2.66%)
At close: Mar 28, 2025, 4:00 PM
9.00
-0.16 (-1.75%)
After-hours: Mar 28, 2025, 7:20 PM EDT
10x Genomics Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$20.00
Upside
+118.34%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +63.76% | Mar 4, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +183.84% | Feb 14, 2025 |
Barclays | Barclays | Buy Maintains $18 → $15 | Buy | Maintains | $18 → $15 | +63.76% | Feb 14, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +96.51% | Feb 13, 2025 |
Citigroup | Citigroup | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +118.34% | Feb 13, 2025 |
JP Morgan | JP Morgan | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +31.00% | Feb 13, 2025 |
UBS | UBS | Hold Maintains $20 → $14 | Hold | Maintains | $20 → $14 | +52.84% | Feb 13, 2025 |
Stifel | Stifel | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +96.51% | Feb 13, 2025 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $25 → $12 | Buy → Hold | Downgrades | $25 → $12 | +31.00% | Feb 13, 2025 |
Barclays | Barclays | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +96.51% | Feb 10, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $30 → $28 | Buy | Maintains | $30 → $28 | +205.68% | Jan 13, 2025 |
Barclays | Barclays | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +107.42% | Nov 1, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $35 → $23 | Strong Buy | Maintains | $35 → $23 | +151.09% | Oct 30, 2024 |
Goldman Sachs | Goldman Sachs | Strong Sell Maintains $16 → $14 | Strong Sell | Maintains | $16 → $14 | +52.84% | Oct 30, 2024 |
JP Morgan | JP Morgan | Hold Maintains $20 → $14 | Hold | Maintains | $20 → $14 | +52.84% | Oct 30, 2024 |
UBS | UBS | Hold Maintains $25 → $20 | Hold | Maintains | $25 → $20 | +118.34% | Oct 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.